I-Zhonghan Biomedical Technology (R)-2-(2, 5-difluorophenyl) indlela yokulungiswa kwe-pyrrolidine ilungelo lobunikazi ligunyazwe ngokusemthethweni

I-Zhonghan (Qihe County) Biomedical Technology Co., Ltd. yamukele izindaba ezinhle! Ngomhla ziyi-14 kuJuni, 2024, Ihhovisi Lempahla Yengqondo Likahulumeni likhiphe ngokusemthethweni isaziso esazisa ukuthi ilungelo lobunikazi lenkampani lendlela yokulungiselela ye-(R)-2-(2, 5-difluorophenyl) pyrrolidine ligunyazwe ngempumelelo. Kusukela ekusetshenzisweni kwaleli lungelo lobunikazi ngoFebhuwari 10, 2022, ngemva kokubuyekezwa okuqinile kanye nenqubo yokuhlola, umphumela wagcina wamukelwe ngemva kweminyaka emibili, futhi ukwamukelwa kwaleli lungelo lobunikazi nakho kuwukuqinisekisa kwemizamo yabasebenzi bocwaningo nentuthuko yenkampani.

Kubikwa ukuthi ilungelo lobunikazi bendlela yokulungiselela liwumphumela wemizamo yeminyaka eminingi yethimba le-R&D le-Zhonghan Biomedical Technology Co., LTD., futhi inobuhlakani obusha nokusebenzayo okubalulekile. Okuqukethwe okuyinhloko kwesicelo selungelo lobunikazi kuhlanganisa ukusetshenziswa kwe-2, 5-difluorobenzene njengento eluhlaza, kuhlanganiswe nochungechunge lwezinyathelo ezinhle zokusabela kwamakhemikhali, indlela ingakwazi ukulungiselela kahle futhi okunobungani kwemvelo kwekhwalithi ephezulu (R) -2- (2, 5-difluorophenyl) pyrrolidine, ehlinzeka ngokusekela okuqinile ekukhiqizeni izinkambu ezihlobene.

Umuntu othintekayo ophethe inkampani uthe ngokujabula: "Ukugunyazwa kwaleli gunya lobunikazi kuyingqopha-mlando emisha yezobuchwepheshe, futhi futhi kuwukuqinisekisa umsebenzi onzima wethimba lethu locwaningo nentuthuko. Ngokuzayo, sizoqhubeka nokunamathela kulokho okuqhutshwa emisha, sizoqhubeka nokwethula impumelelo eyengeziwe yobuchwepheshe obuphezulu ngokuzimela okuzimele ekuthuthukisweni kwamalungelo obunikazi bempahla yengqondo!"

Eminyakeni yamuva nje, i-Zhonghan Pharmaceutical ibilokhu ibambelele emcabangweni wokuthuthukiswa "oqhutshwa emisha", futhi izibophezele ocwaningweni nasekuthuthukisweni nasekukhiqizeni abaphakathi kwezemithi abasezingeni eliphezulu. Esinyathelweni esilandelayo, i-Zhonghan Pharmaceutical izoqhubeka nokwandisa ukutshalwa kwezimali ocwaningweni nasekuthuthukisweni, ithuthukise njalo uhlelo lokuvikela impahla yengqondo, ihlale ithuthukisa izinga lobuchwepheshe, ithuthukise ikhono lokuqamba izinto ezintsha ezizimele, futhi inikeze ukwesekwa okunamandla kwezobuchwepheshe ekuthuthukisweni kwekhwalithi ephezulu kwamabhizinisi. Ukugunyazwa kwelungelo lobunikazi akugcinanga nje ngokuthuthukisa isimo nomthelela we-Zhonghan Biomedicine Technology Co., Ltd. embonini, kodwa futhi kufake umfutho oqinile wentuthuko yesikhathi esizayo yenkampani. Inkampani ikholelwa ukuthi ngaphansi kokuqondisa kobuchwepheshe obusha, ngaphansi kwemizamo engapheli yeqembu lenkampani, i-Zhonghan Biomedical Technology Co., Ltd. izoletha kusasa okugqame kakhulu!